rhodioloside has been researched along with Hepatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, J; Wang, W; Wang, X; Yang, L; Zhou, L | 1 |
| Bo, L; Deng, X; Hu, B; Li, J; Liu, S; Wang, J; Zhu, J; Zou, Y | 1 |
2 other study(ies) available for rhodioloside and Hepatitis
| Article | Year |
|---|---|
Inhibition of HMGB1 involved in the protective of salidroside on liver injury in diabetes mice.
Topics: Animals; Anti-Inflammatory Agents; Blood Glucose; Cell Line; Cytokines; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucosides; Hepatitis; HMGB1 Protein; Humans; Hypoglycemic Agents; Liver; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Phenols; Receptor for Advanced Glycation End Products; Signal Transduction; Toll-Like Receptor 4 | 2020 |
Salidroside attenuates concanavalin A-induced hepatitis via modulating cytokines secretion and lymphocyte migration in mice.
Topics: Animals; Cell Movement; Concanavalin A; Cytokines; Flow Cytometry; Glucosides; Hepatitis; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Phenols | 2014 |